Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Axis-Shield Possible Bidder Backs Away as Alere Raises Stake
Bloomberg
Friday, September 30, 2011 - 10:52am
tags:
Axis-Shield, M&A, Alere, diagnostics
Valeant Pharma Offer Tops Paladin's
Yahoo/Zacks.com
Friday, September 30, 2011 - 9:29am
tags:
Valeant Pharmaceuticals, Paladin, Cephalon, JNJ, Dermik, Sanofi
AstraZeneca settles Seroquel patent litigation
Marketwatch
Friday, September 30, 2011 - 9:27am
tags:
Seroquel, AstraZeneca, patents, Handa, Seroquel XR
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Forbes
Friday, September 30, 2011 - 9:26am
tags:
rivaroxaban, JNJ, Xarelto, acute coronary syndrome, Bayer
Are HIV Drugmakers Doomed?
Motley Fool
Friday, September 30, 2011 - 9:25am
tags:
HIV, Pfizer, Merck, JNJ, Bristol-Myers Squibb, Sangamo BioSciences, Gilead, Abbott Laboratories
Proximagen polishes its CNS rep with $16M Lundbeck deal
Fierce Biotech
Thursday, September 29, 2011 - 11:27am
tags:
Proximagen, Lundbeck, CNS
Narcolepsy Drug Wakes Up Pharmaceutical Stock
Forbes
Thursday, September 29, 2011 - 11:15am
tags:
narcolepsy, Jazz Pharmaceuticals, Xyrem
Pharma R&D and Payers Need to Talk, Yesterday
PharmExec
Thursday, September 29, 2011 - 9:10am
tags:
R&D, drug development
Biotech Investors Bow Out as Hurdles Grow
Bloomberg
Thursday, September 29, 2011 - 9:06am
tags:
investors, Human Genome Sciences, Savient, biotech, Dendreon, Vertex, Acorda
Obama Lawyers Appeal to U.S. High Court for Ruling on Health-Care Overhaul
Bloomberg
Thursday, September 29, 2011 - 9:04am
tags:
healthcare reform, Obama, Supreme Court
Pfizer, pharmacy group warn on counterfeit drugs
Yahoo/AP
Thursday, September 29, 2011 - 9:03am
tags:
Pfizer, drug counterfeiting, Medicines Company
Novo Nordisk's Levemir Gets Support
Yahoo/Zacks.com
Thursday, September 29, 2011 - 9:02am
tags:
Levemir, Novo Nordisk, insulin, type 1 diabetes, Merck, Europe
Analysis: Open-access R&D one answer to drug industry woes
Reuters
Thursday, September 29, 2011 - 8:34am
tags:
R&D, open-access R&D
Merck Pays $1.5M Fine For Pollution Problems
Pharmalot
Thursday, September 29, 2011 - 8:33am
tags:
Merck, pollution
Marshall Edwards Taking Big Pharma Clinical Path
Seeking Alpha
Thursday, September 29, 2011 - 8:32am
tags:
Marshall Edwards, oncology
Merck sells stake in OTC drug venture to J&J unit
Marketwatch
Wednesday, September 28, 2011 - 6:07pm
tags:
OTC, Merck, JNJ, McNeil
Novartis: A Solid Yielding Defensive Play For This Turbulent Market
Seeking Alpha
Wednesday, September 28, 2011 - 6:05pm
tags:
Novartis
Chelsea Therapeutics asks FDA to approve Northera
Yahoo/AP
Wednesday, September 28, 2011 - 12:34pm
tags:
FDA, Northera, Chelsea Therapeutics, Parkinson's Disease
Sequenom Passes This Key Test
Motley Fool
Wednesday, September 28, 2011 - 12:34pm
tags:
Sequenom
Questcor Pharmaceuticals sees Acthar Gel MS prescriptions poised for 3rd-quarter growth
Yahoo/AP
Wednesday, September 28, 2011 - 12:32pm
tags:
Questcor, Acthar, multiple sclerosis, MS

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.